ATE429440T1 - Formen prostataspezifischer antigene und verfahren zu deren nachweis - Google Patents
Formen prostataspezifischer antigene und verfahren zu deren nachweisInfo
- Publication number
- ATE429440T1 ATE429440T1 AT02750561T AT02750561T ATE429440T1 AT E429440 T1 ATE429440 T1 AT E429440T1 AT 02750561 T AT02750561 T AT 02750561T AT 02750561 T AT02750561 T AT 02750561T AT E429440 T1 ATE429440 T1 AT E429440T1
- Authority
- AT
- Austria
- Prior art keywords
- prostate
- forms
- detection
- specific antigens
- ppsa
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
- C12Y304/21—Serine endopeptidases (3.4.21)
- C12Y304/21077—Semenogelase (3.4.21.77), i.e. prostate specific antigen or PSA or kallikrein 3
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
- C12N9/6445—Kallikreins (3.4.21.34; 3.4.21.35)
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57434—Specifically defined cancers of prostate
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Food Science & Technology (AREA)
- Oncology (AREA)
- Cell Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hospice & Palliative Care (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US09/792,692 US7288636B2 (en) | 1997-04-30 | 2001-02-23 | Forms of prostate specific antigens and methods for their detection |
PCT/US2002/005424 WO2002072752A2 (en) | 2001-02-23 | 2002-02-22 | Forms of prostate specific antigens and methods for their detection |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE429440T1 true ATE429440T1 (de) | 2009-05-15 |
Family
ID=25157751
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT02750561T ATE429440T1 (de) | 2001-02-23 | 2002-02-22 | Formen prostataspezifischer antigene und verfahren zu deren nachweis |
Country Status (7)
Country | Link |
---|---|
US (1) | US7288636B2 (de) |
EP (1) | EP1392719B1 (de) |
AT (1) | ATE429440T1 (de) |
AU (1) | AU2002306568A1 (de) |
DE (1) | DE60232069D1 (de) |
ES (1) | ES2324601T3 (de) |
WO (1) | WO2002072752A2 (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7659073B2 (en) | 1997-04-30 | 2010-02-09 | Hybritech Incorporated | Forms of prostate specific antigens and methods for their detection |
WO2009029550A2 (en) * | 2007-08-24 | 2009-03-05 | Singulex, Inc. | Highly sensitive system and methods for analysis of prostate specific antigen (psa) |
US8557777B2 (en) | 2010-07-09 | 2013-10-15 | The Board Of Trustees Of The University Of Illinois | Methods for treating cancer using prostate specific antigen and tumor endothelial marker peptides |
WO2012006634A2 (en) * | 2010-07-09 | 2012-01-12 | The Board Of Trustees Of The University Of Illiniois | Prostate specific antigen (psa) peptide therapy |
WO2012040514A2 (en) * | 2010-09-23 | 2012-03-29 | Biocept, Inc. | Methods and reagents for signal amplification |
SG11201406592QA (en) | 2012-05-04 | 2014-11-27 | Pfizer | Prostate-associated antigens and vaccine-based immunotherapy regimens |
CN105929151A (zh) * | 2016-06-30 | 2016-09-07 | 深圳市亚辉龙生物科技股份有限公司 | 前列腺特异性抗原同源异构体化学发光免疫检测试剂盒及其制备方法 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9002480D0 (sv) * | 1990-07-23 | 1990-07-23 | Hans Lilja | Assay of free and complexed prostate-specific antigen |
PT667920E (pt) | 1992-10-29 | 2003-06-30 | Univ Jefferson | Metodos de deteccao de micrometasteses do cancro da prostata |
US6103237A (en) | 1993-07-22 | 2000-08-15 | Hybritech Incorporated | Stable variant hK2 polypeptide |
US5599677A (en) * | 1993-12-29 | 1997-02-04 | Abbott Laboratories | Immunoassays for prostate specific antigen |
EP0725139A3 (de) | 1995-02-03 | 1997-11-26 | Bayer Corporation | Rekombinantes prostat-spezifisches Antigen und seiner Verwendung als Immunoassay-Kalibrator |
CA2286090C (en) | 1997-04-30 | 2013-01-08 | Hybritech Incorporated | Forms of prostate specific antigen and methods for their detection |
US7674275B2 (en) | 2006-10-05 | 2010-03-09 | Ethicon Endo-Surgery, Inc. | Suture anchor |
-
2001
- 2001-02-23 US US09/792,692 patent/US7288636B2/en not_active Expired - Fee Related
-
2002
- 2002-02-22 EP EP02750561A patent/EP1392719B1/de not_active Expired - Lifetime
- 2002-02-22 AU AU2002306568A patent/AU2002306568A1/en not_active Abandoned
- 2002-02-22 ES ES02750561T patent/ES2324601T3/es not_active Expired - Lifetime
- 2002-02-22 DE DE60232069T patent/DE60232069D1/de not_active Expired - Lifetime
- 2002-02-22 WO PCT/US2002/005424 patent/WO2002072752A2/en active Search and Examination
- 2002-02-22 AT AT02750561T patent/ATE429440T1/de not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
DE60232069D1 (de) | 2009-06-04 |
WO2002072752A2 (en) | 2002-09-19 |
EP1392719A2 (de) | 2004-03-03 |
EP1392719A4 (de) | 2005-10-19 |
EP1392719B1 (de) | 2009-04-22 |
US20020058291A1 (en) | 2002-05-16 |
US7288636B2 (en) | 2007-10-30 |
ES2324601T3 (es) | 2009-08-11 |
WO2002072752A3 (en) | 2003-02-27 |
AU2002306568A1 (en) | 2002-09-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1077602A1 (en) | Use of nucleic acids in preparation of a diagnostic agent for evaluating a disease condition in a patient | |
WO2005010213A3 (en) | Markers for detection of gastric cancer | |
ATE275642T1 (de) | Verfahren zur diagnose von krebs | |
DE60237531D1 (de) | Verfahren zum trennen von seltenen zellen von fluidproben | |
HUP9701717A2 (hu) | Eljárás cPSA-meghatározására | |
WO2002031507A3 (en) | Non-invasive enzyme screen for tissue remodelling-associated conditions | |
WO2006039405A3 (en) | Drug screening and molecular diagnostic test for early detection of colorectal cancer: reagents, methods and kits thereof | |
DE60020529D1 (de) | Antikörper zur krebsbehandlung und -diagnose | |
BRPI0411200A (pt) | método de tratamento de cáncer, métodos de tratamento de paciente humano, artigo industrializado e kit de tratamento de cáncer | |
EP1855719A4 (de) | Neutralisierende monoklonale antikörper gegen coronaviren in zusammenhang mit schwerem akutem atemwegssyndrom | |
SI1535068T1 (sl) | Naprave in postopki za odkrivanje amnijske tekočine v vaginalnih izločkih | |
DE60129151D1 (de) | Verfahren zur erkennung von eierstockkrebs mittels menschlichem kallikrein (hk6) | |
WO2011082345A3 (en) | Compositions and methods for cancer management using antibodies binding to nucleotide salvage pathway enzymes and complexes thereof | |
WO2005040421A3 (en) | Prognostic and diagnostic markers for cell proliferative disorders of the breast tissues | |
ATE429440T1 (de) | Formen prostataspezifischer antigene und verfahren zu deren nachweis | |
AU2002315411A1 (en) | Detection and treatment of prostate cancer | |
ATE404676T1 (de) | Prostat-spezifisches-antigenformen und verfahren zu ihrer bestimmung | |
WO2005069935A3 (en) | METHODS FOR MEASURING TRANSFORMING GROWTH FACTOR BETA (TGF-β) RECEPTOR SIGNALING ACTIVITY AND USES THEREOF | |
ATE445839T1 (de) | Latentes tuberkulose-diagnostisches antigen und verwendungsmethode | |
CA2366514A1 (en) | Diagnostic and therapeutic use of antibodies against the urokinase receptor | |
EP1572225A4 (de) | Thrombospondinfragmente und deren verwendung bei klinischen krebs-tests und der erzeugung von antikörpern und sonstigen bindungsmitteln | |
DE602004013554D1 (de) | Verbindungen und verfahren zur diagnose von prostatakrebs | |
DE60144027D1 (de) | 5t4 rna in plasma und serum als marker für neoplastische erkrankungen | |
DE60309879D1 (de) | Verfahren zur Diagnose von Krebs | |
WO2003050499A3 (de) | Verwendung eines markierten liganden mit spezifität für das humane cd4-molekül |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |